Logo image of CRUS

CIRRUS LOGIC INC (CRUS) Stock Fundamental Analysis

USA - NASDAQ:CRUS - US1727551004 - Common Stock

127.28 USD
+7.16 (+5.96%)
Last: 9/22/2025, 9:37:30 PM
127.28 USD
0 (0%)
After Hours: 9/22/2025, 9:37:30 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CRUS. CRUS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. CRUS gets an excellent profitability rating and is at the same time showing great financial health properties. CRUS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CRUS had positive earnings in the past year.
CRUS had a positive operating cash flow in the past year.
Each year in the past 5 years CRUS has been profitable.
Each year in the past 5 years CRUS had a positive operating cash flow.
CRUS Yearly Net Income VS EBIT VS OCF VS FCFCRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

CRUS has a better Return On Assets (15.26%) than 88.39% of its industry peers.
CRUS has a better Return On Equity (18.14%) than 83.93% of its industry peers.
CRUS has a better Return On Invested Capital (15.52%) than 89.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRUS is above the industry average of 10.87%.
The last Return On Invested Capital (15.52%) for CRUS is above the 3 year average (13.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 15.26%
ROE 18.14%
ROIC 15.52%
ROA(3y)11.7%
ROA(5y)12.47%
ROE(3y)14.26%
ROE(5y)15.76%
ROIC(3y)13.7%
ROIC(5y)13.38%
CRUS Yearly ROA, ROE, ROICCRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 18.15%, CRUS belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
CRUS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 22.60%, CRUS belongs to the top of the industry, outperforming 82.14% of the companies in the same industry.
CRUS's Operating Margin has improved in the last couple of years.
CRUS's Gross Margin of 52.93% is fine compared to the rest of the industry. CRUS outperforms 70.54% of its industry peers.
In the last couple of years the Gross Margin of CRUS has remained more or less at the same level.
Industry RankSector Rank
OM 22.6%
PM (TTM) 18.15%
GM 52.93%
OM growth 3Y1.72%
OM growth 5Y7.25%
PM growth 3Y-1.55%
PM growth 5Y7.03%
GM growth 3Y0.44%
GM growth 5Y-0.04%
CRUS Yearly Profit, Operating, Gross MarginsCRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. Health

2.1 Basic Checks

CRUS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRUS has less shares outstanding
The number of shares outstanding for CRUS has been reduced compared to 5 years ago.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRUS Yearly Shares OutstandingCRUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CRUS Yearly Total Debt VS Total AssetsCRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

CRUS has an Altman-Z score of 12.80. This indicates that CRUS is financially healthy and has little risk of bankruptcy at the moment.
CRUS has a better Altman-Z score (12.80) than 78.57% of its industry peers.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.8
ROIC/WACC1.35
WACC11.49%
CRUS Yearly LT Debt VS Equity VS FCFCRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 6.58 indicates that CRUS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.58, CRUS belongs to the best of the industry, outperforming 84.82% of the companies in the same industry.
A Quick Ratio of 5.10 indicates that CRUS has no problem at all paying its short term obligations.
The Quick ratio of CRUS (5.10) is better than 83.93% of its industry peers.
Industry RankSector Rank
Current Ratio 6.58
Quick Ratio 5.1
CRUS Yearly Current Assets VS Current LiabilitesCRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CRUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.62%, which is quite good.
CRUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.60% yearly.
CRUS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.52%.
The Revenue has been growing by 8.16% on average over the past years. This is quite good.
EPS 1Y (TTM)12.62%
EPS 3Y3%
EPS 5Y13.6%
EPS Q2Q%34.82%
Revenue 1Y (TTM)4.52%
Revenue growth 3Y2.1%
Revenue growth 5Y8.16%
Sales Q2Q%8.89%

3.2 Future

CRUS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.19% yearly.
Based on estimates for the next years, CRUS will show a small growth in Revenue. The Revenue will grow by 0.75% on average per year.
EPS Next Y-3.02%
EPS Next 2Y0.97%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue Next Year0.26%
Revenue Next 2Y2.84%
Revenue Next 3Y0.75%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRUS Yearly Revenue VS EstimatesCRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CRUS Yearly EPS VS EstimatesCRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.03, which indicates a correct valuation of CRUS.
Compared to the rest of the industry, the Price/Earnings ratio of CRUS indicates a rather cheap valuation: CRUS is cheaper than 93.75% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, CRUS is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.54, CRUS is valued correctly.
Based on the Price/Forward Earnings ratio, CRUS is valued cheaply inside the industry as 88.39% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.87. CRUS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.03
Fwd PE 16.54
CRUS Price Earnings VS Forward Price EarningsCRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRUS is valued cheaply inside the industry as 90.18% of the companies are valued more expensively.
CRUS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRUS is cheaper than 94.64% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.46
EV/EBITDA 12
CRUS Per share dataCRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of CRUS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.18
EPS Next 2Y0.97%
EPS Next 3Y-1.19%

0

5. Dividend

5.1 Amount

No dividends for CRUS!.
Industry RankSector Rank
Dividend Yield N/A

CIRRUS LOGIC INC

NASDAQ:CRUS (9/22/2025, 9:37:30 PM)

After market: 127.28 0 (0%)

127.28

+7.16 (+5.96%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners98.94%
Inst Owner Change-1.91%
Ins Owners0.49%
Ins Owner Change0.45%
Market Cap6.53B
Analysts81.43
Price Target127.11 (-0.13%)
Short Float %2.77%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.01%
Min EPS beat(2)35.11%
Max EPS beat(2)38.92%
EPS beat(4)4
Avg EPS beat(4)24.79%
Min EPS beat(4)9.26%
Max EPS beat(4)38.92%
EPS beat(8)8
Avg EPS beat(8)40.31%
EPS beat(12)12
Avg EPS beat(12)37.06%
EPS beat(16)16
Avg EPS beat(16)34.03%
Revenue beat(2)2
Avg Revenue beat(2)9.51%
Min Revenue beat(2)9.42%
Max Revenue beat(2)9.59%
Revenue beat(4)4
Avg Revenue beat(4)6.96%
Min Revenue beat(4)2.07%
Max Revenue beat(4)9.59%
Revenue beat(8)8
Avg Revenue beat(8)9.19%
Revenue beat(12)11
Avg Revenue beat(12)8.5%
Revenue beat(16)15
Avg Revenue beat(16)8.02%
PT rev (1m)1.16%
PT rev (3m)1.16%
EPS NQ rev (1m)3.3%
EPS NQ rev (3m)14.52%
EPS NY rev (1m)0%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)1.81%
Revenue NQ rev (3m)7.59%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 16.03
Fwd PE 16.54
P/S 3.39
P/FCF 14.46
P/OCF 13.8
P/B 3.38
P/tB 4.45
EV/EBITDA 12
EPS(TTM)7.94
EY6.24%
EPS(NY)7.7
Fwd EY6.05%
FCF(TTM)8.8
FCFY6.92%
OCF(TTM)9.22
OCFY7.24%
SpS37.59
BVpS37.61
TBVpS28.61
PEG (NY)N/A
PEG (5Y)1.18
Profitability
Industry RankSector Rank
ROA 15.26%
ROE 18.14%
ROCE 20.7%
ROIC 15.52%
ROICexc 21.92%
ROICexgc 31.75%
OM 22.6%
PM (TTM) 18.15%
GM 52.93%
FCFM 23.43%
ROA(3y)11.7%
ROA(5y)12.47%
ROE(3y)14.26%
ROE(5y)15.76%
ROIC(3y)13.7%
ROIC(5y)13.38%
ROICexc(3y)18.68%
ROICexc(5y)18.11%
ROICexgc(3y)27.43%
ROICexgc(5y)27.07%
ROCE(3y)18.28%
ROCE(5y)17.85%
ROICexcg growth 3Y-2.62%
ROICexcg growth 5Y9.35%
ROICexc growth 3Y2.54%
ROICexc growth 5Y8.89%
OM growth 3Y1.72%
OM growth 5Y7.25%
PM growth 3Y-1.55%
PM growth 5Y7.03%
GM growth 3Y0.44%
GM growth 5Y-0.04%
F-Score9
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.3%
Cap/Sales 1.11%
Interest Coverage 250
Cash Conversion 97.05%
Profit Quality 129.09%
Current Ratio 6.58
Quick Ratio 5.1
Altman-Z 12.8
F-Score9
WACC11.49%
ROIC/WACC1.35
Cap/Depr(3y)62.46%
Cap/Depr(5y)55.84%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.76%
Profit Quality(3y)145.47%
Profit Quality(5y)123.32%
High Growth Momentum
Growth
EPS 1Y (TTM)12.62%
EPS 3Y3%
EPS 5Y13.6%
EPS Q2Q%34.82%
EPS Next Y-3.02%
EPS Next 2Y0.97%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue 1Y (TTM)4.52%
Revenue growth 3Y2.1%
Revenue growth 5Y8.16%
Sales Q2Q%8.89%
Revenue Next Year0.26%
Revenue Next 2Y2.84%
Revenue Next 3Y0.75%
Revenue Next 5YN/A
EBIT growth 1Y16.46%
EBIT growth 3Y3.86%
EBIT growth 5Y16%
EBIT Next Year16.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y146.16%
FCF growth 3Y63.67%
FCF growth 5Y8.67%
OCF growth 1Y110%
OCF growth 3Y52.7%
OCF growth 5Y8.48%